Global Pentavalent Vaccine Market size was valued at USD 2.73 Bn. in 2024 and the total Pentavalent Vaccine Market revenue is expected to grow by 3.3% from 2025 to 2032, reaching nearly USD 3.54 Bn.Pentavalent Vaccine Market Overview:
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).To know about the Research Methodology :- Request Free Sample Report
Pentavalent Vaccine Market Dynamics:
The market for pentavalent vaccines is quickly increasing due to the rising prevalence of Diphtheria, Tetanus, Pertussis, and Hepatitis B. In terms of equipment, delivery, and disposal, the pentavalent vaccine saves money. Emerging manufacturers are making significant investments in the industry, including component vaccine procurement, technology transfers, clinical and analytical development, registration and prequalification efforts, and growing manufacturing capacity to meet rising demand. Market interventions such as WHO technical help to manufacturers and PATH-facilitated technical assistance to numerous manufacturers financed by the BMGF are aimed at increasing production efficiency and improving production economics, mainly for older manufacturing methods for DTwP. Panacea Biotech won orders for pentavalent vaccine worth USD 24.32 million (about Rs 170 crores) from UN agencies including UNICEF in 2019. UN agencies (UNICEF and PAHO) have awarded Panacea Biotech USD 24.32 million for the supply of its Easyfive-TT, a totally liquid WHO prequalified wP-based pentavalent vaccination. UNICEF estimates that global pentavalent vaccination demand was reached at 449 million doses by 2019, averaging 150 million doses per year.Pentavalent Vaccine Market Segment Analysis:
Based on the Formulation Type, the market is segmented into Lyophilized and Liquid. Liquid formulation type segment is expected to hold the largest Pentavalent Vaccine market share of xx% by 2032. Both liquid and Lyophilized pentavalent (DTP-Hep B-Hib) vaccines are available. However, because the combined DTP-Hep B component is available in liquid form and the Hib component is freeze dried, the latter must be reconstituted (blended) before use. Given the convenience of utilising liquid form Pentavalent (DTP-HepB-Hib) vaccine at busy immunisation clinics, it was agreed to employ liquid form Pentavalent (DTP-HepB-Hib) vaccine in the national EPI programme. Only a single dose liquid form of the Pentavalent (DTP-HepB-Hib) vaccination is now available. Hib vaccinations have been licenced in India for about a decade and are routinely used in the private sector. The powdered form's longer shelf life, precise formulation, and great effectiveness are all contributing to the segment's rise. Based on the Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, and E-commerce. Retail Pharmacy segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2025-2032. Due to favourable demographic circumstances and an epidemiological change, India's pharmacy retail sector has grown significantly in recent years. Retail pharmacies are increasing their patient-care programmes. Patients prefer to buy pharmaceuticals from retail pharmacies rather than hospitals; therefore, this segment is expected to maintain its dominance during the forecast period 2025-2032.Pentavalent Vaccine Market Regional Insights:
North America region is expected to dominate the Pentavalent Vaccine market during the forecast period 2024-2030. North America region is expected to hold the largest market shares of xx% by 2030. The North American regional pentavalent vaccine market is booming due to increased insurance coverage, the presence of R&D centres and institutes, and government funding. The market's growth is additionally influenced by well-established healthcare infrastructure, simplicity of access, and increasing immunisation programmes. The market's growth has been aided by investments from key players in the industry. Europe is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. The increased acceptance of emerging advanced technologies, as well as the rising prevalence of Hep-B and tetanus, are expected to drive the market forward in Europe. Asia Pacific is expected to grow rapidly at a CAGR of xx% during the forecast period 2024-2030. This is due to increased health-care expenditures. The market demand is expected to be driven by the allocation of a significant amount of healthcare spending for hospitals and dispensing medicines to the elderly. Government-mandated and free immunisation programmes are also driving the market in the Asia Pacific region. The objective of the report is to present a comprehensive analysis of the Global Pentavalent Vaccine Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Pentavalent Vaccine Market dynamic, structure by analyzing the market segments and project the Global Pentavalent Vaccine Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Pentavalent Vaccine Market make the report investor’s guide.Pentavalent Vaccine Market Scope: Inquire before Buying
Pentavalent Vaccine Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 2.73 Bn. Forecast Period 2025 to 2032 CAGR: 3.3% Market Size in 2032: USD 3.54 Bn. Segments Covered: by Formulation Type Lyophilized Liquid by Distribution Channel Retail Pharmacy Hospital Pharmacy E-commerce by Application Hospital Pharmacy Retail Pharmacy Online Pharmacy Pentavalent Vaccine Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Pentavalent Vaccine Market, Key Players
1.Serum Institute of India 2.Panacea Drugs Pvt. Ltd 3.Shantha Biotechnics 4.Biological E. Ltd. 5.Novartis AG 6.Crucell 7.Bio Farma Frequently Asked Questions: 1] What segments are covered in Pentavalent Vaccine Market report? Ans. The segments covered in Pentavalent Vaccine Market report are based on Formulation Type, Distribution Channel and Application. 2] Which region is expected to hold the highest share in the Pentavalent Vaccine Market? Ans. North America is expected to hold the highest share in the Pentavalent Vaccine Market. 3] Who are the top key players in the Pentavalent Vaccine Market? Ans. Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., and Novartis AG are the top key players in the Pentavalent Vaccine Market. 4] Which segment holds the largest market share in the Pentavalent Vaccine market Based on its formulation Type by 2032? Ans. Liquid formulation type segment hold the largest market share in the Pentavalent Vaccine market by 2032 based on its formulation type. 5] What is the market size of the Pentavalent Vaccine market by 2032? Ans. The market size of the Pentavalent Vaccine market is expected to reach USD 3.54 Bn. by 2032.
1. Pentavalent Vaccine Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Pentavalent Vaccine Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading Pentavalent Vaccine Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Pentavalent Vaccine Market: Dynamics 3.1. Pentavalent Vaccine Market Trends by Region 3.1.1. North America Pentavalent Vaccine Market Trends 3.1.2. Europe Pentavalent Vaccine Market Trends 3.1.3. Asia Pacific Pentavalent Vaccine Market Trends 3.1.4. Middle East and Africa Pentavalent Vaccine Market Trends 3.1.5. South America Pentavalent Vaccine Market Trends 3.2. Pentavalent Vaccine Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Pentavalent Vaccine Market Drivers 3.2.1.2. North America Pentavalent Vaccine Market Restraints 3.2.1.3. North America Pentavalent Vaccine Market Opportunities 3.2.1.4. North America Pentavalent Vaccine Market Challenges 3.2.2. Europe 3.2.2.1. Europe Pentavalent Vaccine Market Drivers 3.2.2.2. Europe Pentavalent Vaccine Market Restraints 3.2.2.3. Europe Pentavalent Vaccine Market Opportunities 3.2.2.4. Europe Pentavalent Vaccine Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Pentavalent Vaccine Market Drivers 3.2.3.2. Asia Pacific Pentavalent Vaccine Market Restraints 3.2.3.3. Asia Pacific Pentavalent Vaccine Market Opportunities 3.2.3.4. Asia Pacific Pentavalent Vaccine Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Pentavalent Vaccine Market Drivers 3.2.4.2. Middle East and Africa Pentavalent Vaccine Market Restraints 3.2.4.3. Middle East and Africa Pentavalent Vaccine Market Opportunities 3.2.4.4. Middle East and Africa Pentavalent Vaccine Market Challenges 3.2.5. South America 3.2.5.1. South America Pentavalent Vaccine Market Drivers 3.2.5.2. South America Pentavalent Vaccine Market Restraints 3.2.5.3. South America Pentavalent Vaccine Market Opportunities 3.2.5.4. South America Pentavalent Vaccine Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Pentavalent Vaccine Industry 3.8. Analysis of Government Schemes and Initiatives For Pentavalent Vaccine Industry 3.9. Pentavalent Vaccine Market Trade Analysis 3.10. The Global Pandemic Impact on Pentavalent Vaccine Market 4. Pentavalent Vaccine Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 4.1.1. Lyophilized 4.1.2. Liquid 4.2. Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 4.2.1. Retail Pharmacy 4.2.2. Hospital Pharmacy 4.2.3. E-commerce 4.3. Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 4.3.1. Hospital Pharmacy 4.3.2. Retail Pharmacy 4.3.3. Online Pharmacy 4.4. Pentavalent Vaccine Market Size and Forecast, by Region (2024-2032) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Pentavalent Vaccine Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 5.1.1. Lyophilized 5.1.2. Liquid 5.2. North America Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 5.2.1. Retail Pharmacy 5.2.2. Hospital Pharmacy 5.2.3. E-commerce 5.3. North America Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 5.3.1. Hospital Pharmacy 5.3.2. Retail Pharmacy 5.3.3. Online Pharmacy 5.4. North America Pentavalent Vaccine Market Size and Forecast, by Country (2024-2032) 5.4.1. United States 5.4.1.1. United States Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 5.4.1.1.1. Lyophilized 5.4.1.1.2. Liquid 5.4.1.2. United States Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 5.4.1.2.1. Retail Pharmacy 5.4.1.2.2. Hospital Pharmacy 5.4.1.2.3. E-commerce 5.4.1.3. United States Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 5.4.1.3.1. Hospital Pharmacy 5.4.1.3.2. Retail Pharmacy 5.4.1.3.3. Online Pharmacy 5.4.2. Canada 5.4.2.1. Canada Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 5.4.2.1.1. Lyophilized 5.4.2.1.2. Liquid 5.4.2.2. Canada Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 5.4.2.2.1. Retail Pharmacy 5.4.2.2.2. Hospital Pharmacy 5.4.2.2.3. E-commerce 5.4.2.3. Canada Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 5.4.2.3.1. Hospital Pharmacy 5.4.2.3.2. Retail Pharmacy 5.4.2.3.3. Online Pharmacy 5.4.3. Mexico 5.4.3.1. Mexico Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 5.4.3.1.1. Lyophilized 5.4.3.1.2. Liquid 5.4.3.2. Mexico Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 5.4.3.2.1. Retail Pharmacy 5.4.3.2.2. Hospital Pharmacy 5.4.3.2.3. E-commerce 5.4.3.3. Mexico Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 5.4.3.3.1. Hospital Pharmacy 5.4.3.3.2. Retail Pharmacy 5.4.3.3.3. Online Pharmacy 6. Europe Pentavalent Vaccine Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.2. Europe Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.3. Europe Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4. Europe Pentavalent Vaccine Market Size and Forecast, by Country (2024-2032) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.1.2. United Kingdom Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.1.3. United Kingdom Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.2. France 6.4.2.1. France Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.2.2. France Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.2.3. France Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.3. Germany 6.4.3.1. Germany Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.3.2. Germany Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.3.3. Germany Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.4. Italy 6.4.4.1. Italy Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.4.2. Italy Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.4.3. Italy Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.5. Spain 6.4.5.1. Spain Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.5.2. Spain Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.5.3. Spain Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.6. Sweden 6.4.6.1. Sweden Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.6.2. Sweden Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.6.3. Sweden Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.7. Austria 6.4.7.1. Austria Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.7.2. Austria Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.7.3. Austria Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 6.4.8.2. Rest of Europe Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 6.4.8.3. Rest of Europe Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7. Asia Pacific Pentavalent Vaccine Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.2. Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.3. Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4. Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Country (2024-2032) 7.4.1. China 7.4.1.1. China Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.1.2. China Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.1.3. China Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.2. S Korea 7.4.2.1. S Korea Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.2.2. S Korea Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.2.3. S Korea Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.3. Japan 7.4.3.1. Japan Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.3.2. Japan Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.3.3. Japan Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.4. India 7.4.4.1. India Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.4.2. India Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.4.3. India Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.5. Australia 7.4.5.1. Australia Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.5.2. Australia Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.5.3. Australia Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.6. Indonesia 7.4.6.1. Indonesia Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.6.2. Indonesia Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.6.3. Indonesia Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.7. Malaysia 7.4.7.1. Malaysia Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.7.2. Malaysia Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.7.3. Malaysia Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.8. Vietnam 7.4.8.1. Vietnam Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.8.2. Vietnam Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.8.3. Vietnam Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.9. Taiwan 7.4.9.1. Taiwan Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.9.2. Taiwan Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.9.3. Taiwan Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 7.4.10.2. Rest of Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 7.4.10.3. Rest of Asia Pacific Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 8. Middle East and Africa Pentavalent Vaccine Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 8.2. Middle East and Africa Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 8.3. Middle East and Africa Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 8.4. Middle East and Africa Pentavalent Vaccine Market Size and Forecast, by Country (2024-2032) 8.4.1. South Africa 8.4.1.1. South Africa Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 8.4.1.2. South Africa Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 8.4.1.3. South Africa Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 8.4.2. GCC 8.4.2.1. GCC Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 8.4.2.2. GCC Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 8.4.2.3. GCC Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 8.4.3. Nigeria 8.4.3.1. Nigeria Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 8.4.3.2. Nigeria Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 8.4.3.3. Nigeria Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 8.4.4.2. Rest of ME&A Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 8.4.4.3. Rest of ME&A Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 9. South America Pentavalent Vaccine Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 9.2. South America Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 9.3. South America Pentavalent Vaccine Market Size and Forecast, by Application(2024-2032) 9.4. South America Pentavalent Vaccine Market Size and Forecast, by Country (2024-2032) 9.4.1. Brazil 9.4.1.1. Brazil Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 9.4.1.2. Brazil Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 9.4.1.3. Brazil Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 9.4.2. Argentina 9.4.2.1. Argentina Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 9.4.2.2. Argentina Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 9.4.2.3. Argentina Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Pentavalent Vaccine Market Size and Forecast, by Formulation Type (2024-2032) 9.4.3.2. Rest Of South America Pentavalent Vaccine Market Size and Forecast, by Distribution Channel (2024-2032) 9.4.3.3. Rest Of South America Pentavalent Vaccine Market Size and Forecast, by Application (2024-2032) 10. Company Profile: Key Players 10.1. Serum Institute of India 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Panacea Drugs Pvt. Ltd 10.3. Shantha Biotechnics 10.4. Biological E. Ltd. 10.5. Novartis AG 10.6. Crucell 10.7. Bio Farma 11. Key Findings 12. Industry Recommendations 13. Pentavalent Vaccine Market: Research Methodology 14. Terms and Glossary
